NEJM June 3, 2023
Frank R. Lin, M.D., Ph.D., and Shelly Chadha, M.B., B.S., Ph.D.

On October 17, 2022, the Food and Drug Administration (FDA) enacted regulations permitting the sale of a new class of over-the-counter (OTC) hearing aids that would be available to adults without the need to see a health professional.1 This action represented an attempt to help address the long-standing public health and market failure of hearing loss remaining largely untreated in U.S. adults. This public health challenge is not unique to the United States, however, and the introduction of OTC hearing aids in the United States may influence the hearing-care market in other countries in the coming years.

Studies over the past decade have revealed the public health implications of hearing loss in older adults, and hearing loss is now considered...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Medical Devices, Patient / Consumer, Provider, Public Health / COVID, Regulations
Related Articles:
Your Earphones And Headphones As Health And Medical Devices
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace

Share This Article